BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 32271189)

  • 1. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions.
    Kojima F; Gandhi JS; Matsuzaki I; Iba A; Collier S; Yoshikawa T; Kinoshita Y; Warigaya K; Fujimoto M; Kuroda N; Morii E; Hara I; Murata SI; Amin MB
    Am J Surg Pathol; 2020 Aug; 44(8):1031-1039. PubMed ID: 32271189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
    Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
    Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired cystic disease-associated renal cell carcinoma: A clinicopathologic study of eight tumors with clinical follow-up.
    Chrabańska M; Ryszawy J; Drozdzowska B
    Indian J Cancer; 2021; 58(4):608-614. PubMed ID: 34975102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases].
    Zhang W; Xu LL; Yu WJ; Wang Q; Jiang YX; Liu Y; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):366-371. PubMed ID: 29783804
    [No Abstract]   [Full Text] [Related]  

  • 5. [A Case of ACD-Associated RCC with Lymph Node Metastasis and Contralateral Renal Carcinoma after Nephrectomy].
    Makino Y; Tsuchihashi K; Shimizu Y; Kanamaru S; Hashimoto K; Ito N
    Hinyokika Kiyo; 2016 Jul; 62(7):349-53. PubMed ID: 27569352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired cystic disease-associated renal cell carcinoma: a clinicopathological study of seven cases.
    Kuroda N; Naroda T; Tamura M; Yorita K; Kojima F; Murata SI
    Pol J Pathol; 2017; 68(4):306-311. PubMed ID: 29517200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
    Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral and Multifocal Acquired Cystic Disease-Associated Renal Cell Carcinomas in Patient With End-Stage Renal Disease Caused by Systemic Lupus Erythematosus.
    Chrabańska M; Jakub R; Bogna D
    Int J Surg Pathol; 2021 Apr; 29(2):198-204. PubMed ID: 32513033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired cystic disease and renal cell carcinoma in hemodialysis patients--A case report on three patients.
    Mijušković M; Milović N; Kovačević B; Jovanović D; Stefanović D; Ignjatović L; Terzić B; Pilčević JT; Petrović M; Pilčević D; Obrencević K; Cerović S
    Vojnosanit Pregl; 2015 Oct; 72(10):932-6. PubMed ID: 26665561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
    Kondo T; Sassa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathology; 2021 Oct; 53(6):720-727. PubMed ID: 33947521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcomatoid acquired cystic disease-associated renal cell carcinoma.
    Kuroda N; Tamura M; Taguchi T; Tominaga A; Hes O; Michal M; Ohara M; Hirouchi T; Mizuno K; Hayashi Y; Shuin T; Lee GH
    Histol Histopathol; 2008 Nov; 23(11):1327-31. PubMed ID: 18785115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features.
    Kuroda N; Tamura M; Hamaguchi N; Mikami S; Pan CC; Brunelli M; Martignoni G; Hes O; Michal M; Lee GH
    Ann Diagn Pathol; 2011 Dec; 15(6):462-6. PubMed ID: 21036640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paneth-like cells in renal cell carcinomas and in cysts associated with acquired cystic kidney disease: Clinicopathologic analysis, comparative study and description of precursor lesions.
    Kojima F; Alaghehbandan R; Kuroda N; Matsuzaki I; Mikasa Y; Musangile FY; Iwamoto R; Takahashi Y; Iwahashi Y; Warigaya K; Iba A; Hara I; Murata SI; Hes O
    Ann Diagn Pathol; 2021 Apr; 51():151707. PubMed ID: 33516060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
    Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
    Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features.
    Ahn S; Kwon GY; Cho YM; Jun SY; Choi C; Kim HJ; Park YW; Park WS; Shim JW
    Med Mol Morphol; 2013 Dec; 46(4):225-32. PubMed ID: 23471757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.
    Zhao M; Teng X; Ru G; Zhao Z; Hu Q; Han L; He X
    Int J Clin Exp Pathol; 2015; 8(9):11124-31. PubMed ID: 26617832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women.
    Trpkov K; Hes O; Bonert M; Lopez JI; Bonsib SM; Nesi G; Comperat E; Sibony M; Berney DM; Martinek P; Bulimbasic S; Suster S; Sangoi A; Yilmaz A; Higgins JP; Zhou M; Gill AJ; Przybycin CG; Magi-Galluzzi C; McKenney JK
    Am J Surg Pathol; 2016 Jan; 40(1):60-71. PubMed ID: 26414221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tumors in end-stage renal disease: A comprehensive review.
    Tsuzuki T; Iwata H; Murase Y; Takahara T; Ohashi A
    Int J Urol; 2018 Sep; 25(9):780-786. PubMed ID: 30066367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.